2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Lymphoid
6
Breast
5
Head & Neck
4
Gastrointestinal
4
Classical hematology
4
Gynecologic
3
Thoracic
2
Other hematologic neoplasm
2
Genitourinary
2
CNS
2
Other solid neoplasm
1
Other
1
Endocrine
1
Dermatologic
1
Conditions
Prostatic Neoplasms
6258
Carcinoma, Renal Cell
1910
Urinary Bladder Neoplasms
1669
Kidney Neoplasms
929
Breast Neoplasms
792
Neoplasms
786
Carcinoma, Transitional Cell
590
Carcinoma, Non-Small-Cell Lung
522
Neoplasm Metastasis
510
Melanoma
484
Ovarian Neoplasms
466
Colorectal Neoplasms
451
Lung Neoplasms
435
Pancreatic Neoplasms
325
Testicular Neoplasms
289
Stomach Neoplasms
273
Sarcoma
265
Uterine Cervical Neoplasms
262
Non-Muscle Invasive Bladder Neoplasms
262
Head and Neck Neoplasms
241
Colonic Neoplasms
217
Esophageal Neoplasms
202
Squamous Cell Carcinoma of Head and Neck
200
Wilms Tumor
196
Carcinoma, Hepatocellular
195
Endometrial Neoplasms
188
Recurrence
162
Neuroblastoma
148
Urologic Neoplasms
147
Small Cell Lung Carcinoma
144
Interventions
Palliative Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Stress Disorders, Post-Traumatic
×
Genitourinary
×
Clear all
NCT03652298
2026-03-13
NeuroPrevPTSD
Centre Oscar Lambret
Phase 2
Terminated
19 enrolled
NCT06583395
2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
3,000 enrolled